{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:12:27Z","timestamp":1788642747611,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ70036"],"award-info":[{"award-number":["2023JJ70036"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinic Research Foundation of Aier Eye Hospital Group","award":["AIM2301D06"],"award-info":[{"award-number":["AIM2301D06"]}]},{"name":"the Key Technologies for Myopia Prevention, Control, Diagnosis and Treatment in Children and Adolescents","award":["2019SK2051"],"award-info":[{"award-number":["2019SK2051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40123-026-01467-1","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:07:58Z","timestamp":1786705678000},"page":"3335-3348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular Surface Outcomes with Different 0.05% Atropine Dosing Frequencies in Children with Myopia: A Secondary Analysis of a Randomized Trial"],"prefix":"10.1007","volume":"15","author":[{"given":"Minsong","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QingLin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenYu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-557X","authenticated-orcid":false,"given":"Xiaoning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"2","key":"1467_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/bjo-2023-323887","volume":"109","author":"XJ Zhang","year":"2025","unstructured":"Zhang XJ, Zaabaar E, French AN, et al. Advances in myopia control strategies for children. Br J Ophthalmol. 2025;109(2):165\u201376.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1467_CR2","volume":"2","author":"JG Lawrenson","year":"2025","unstructured":"Lawrenson JG, Huntjens B, Virgili G, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2025;2(2):Cd014758.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1467_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","volume":"46","author":"A Upadhyay","year":"2020","unstructured":"Upadhyay A, Beuerman RW. Biological mechanisms of atropine control of myopia. Eye Contact Lens. 2020;46(3):129\u201335.","journal-title":"Eye Contact Lens"},{"issue":"1","key":"1467_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102317","volume":"48","author":"X Cao","year":"2025","unstructured":"Cao X, Guo Z, Wei Z, et al. Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese children. Contact Lens Anterior Eye. 2025;48(1):102317.","journal-title":"Contact Lens Anterior Eye"},{"key":"1467_CR5","doi-asserted-by":"crossref","unstructured":"Wang H, Piao J, Yoo G, et al. Investigation into the therapeutic efficacy and inflammatory modulatory effects of the combined use of 0.01% atropine eye drops and orthokeratology lenses in the management of myopia among adolescent patients. J Inflamm Res. 2025;18: 12077\u201312087.","DOI":"10.2147\/JIR.S539831"},{"key":"1467_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2147\/TCRM.S265945","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Yang Y, Kong X, et al. The effect of 0.01% atropine eye drops on the ocular surface in children for the control of myopia-the primary results from a six-month prospective study. Ther Clin Risk Manag. 2020;16:735\u201340.","journal-title":"Ther Clin Risk Manag"},{"key":"1467_CR7","doi-asserted-by":"crossref","unstructured":"Li X, Zhu Y, Xie H, et al. Changes in the ocular surface and meibomian glands following administration of 0.01 and 0.02% atropine. Front Med (Lausanne), 2025;12: 1585396.","DOI":"10.3389\/fmed.2025.1585396"},{"key":"1467_CR8","unstructured":"Yam J C, Jiang Y, Tang S M, et al. Low-concentration atropine for myopia progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial Of 0.05%, 0.025%, And 0.01% Atropine Eye Drops In Myopia Control. Ophthalmology. 2019;126(1): 113\u2013124."},{"issue":"2","key":"1467_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jamaophthalmol.2024.5703","volume":"143","author":"J Loughman","year":"2025","unstructured":"Loughman J, Lingham G, Nkansah EK, et al. Efficacy and safety of different atropine regimens for the treatment of myopia in children: three-year results of the MOSAIC randomized clinical trial. JAMA Ophthalmol. 2025;143(2):134\u201344.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"1467_CR10","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.4.22","volume":"13","author":"Y Luo","year":"2024","unstructured":"Luo Y, Yin Z, Zhang J, et al. Differential impact of 0.01% and 0.05% atropine eyedrops on ocular surface in young adults. Transl Vis Sci Technol. 2024;13(4):22.","journal-title":"Transl Vis Sci Technol"},{"key":"1467_CR11","doi-asserted-by":"crossref","unstructured":"Yang Y, Xue M, Hao J, et al. Frequency-dependent effects of 0.05% atropine eyedrops on myopia progression and peripheral defocus: a prospective study. Eye Vis (Lond). 2024;11(1): 26.","DOI":"10.1186\/s40662-024-00395-0"},{"issue":"12","key":"1467_CR12","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1007\/s40123-025-01257-1","volume":"14","author":"W Pan","year":"2025","unstructured":"Pan W, Wu H, Tang Y, et al. Resolution of near-work-related effects, accommodation, and binocular vision changes of 0.05% atropine after 1 year: secondary analysis of a prospective study. Ophthalmol Ther. 2025;14(12):3047\u201357.","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"1467_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40123-026-01341-0","volume":"15","author":"M Korenfeld","year":"2026","unstructured":"Korenfeld M, Hurcikova M, Tatsuoka K, et al. Study of atropine to reduce (STAR) myopia progression in children: 24-month results of a randomized, double-masked, vehicle-controlled trial of atropine sulfate 0.01% and 0.03. Ophthalmol Ther. 2026;15(5):1685\u2013703.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1467_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ame2.12218","volume":"5","author":"A S\u00e1nchez-R\u00edos","year":"2022","unstructured":"S\u00e1nchez-R\u00edos A, Correa-Gallegos EY, Medina-Espinoza JM, et al. Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate. Anim Model Exp Med. 2022;5(3):266\u201373.","journal-title":"Anim Model Exp Med"},{"key":"1467_CR15","doi-asserted-by":"crossref","unstructured":"Li M, Chen Y, Chen J, et al. Short-term effects of ophthalmic topical 0.01% atropine on the ocular surface, pupil size, and subsequent subjective quality of vision in young myopic Chinese adults. Front Med (Lausanne). 2024;11: 1436551.","DOI":"10.3389\/fmed.2024.1436551"},{"issue":"1","key":"1467_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71710-7","volume":"10","author":"WH Cho","year":"2020","unstructured":"Cho WH, Fang PC, Yu HJ, et al. Analysis of tear film spatial instability for pediatric myopia under treatment. Sci Rep. 2020;10(1):14789.","journal-title":"Sci Rep"},{"key":"1467_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-026-00493-1","author":"M Lin","year":"2026","unstructured":"Lin M, Shu W, Hua G, et al. Network pharmacology and molecular dynamics simulations reveal shared mechanisms and myopia-specific targets of atropine in myopia and dry eye disease. Eye Vis. 2026;13(1):27.","journal-title":"Eye Vis"},{"issue":"3","key":"1467_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jtos.2014.04.001","volume":"12","author":"JR Cai","year":"2014","unstructured":"Cai JR, Shan XF, Cai ZG, et al. A new treatment for epiphora secondary to submandibular gland transplantation: transcutaneous atropine gel. Ocul Surf. 2014;12(3):221\u20136.","journal-title":"Ocul Surf"},{"issue":"11","key":"1467_CR19","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s40123-025-01243-7","volume":"14","author":"Y Hsia","year":"2025","unstructured":"Hsia Y, Chen PJ, Ma IH, et al. Intraocular pressure trends in children with myopia receiving atropine therapy. Ophthalmol Ther. 2025;14(11):2849\u201361.","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01467-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01467-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01467-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:03:18Z","timestamp":1788642198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01467-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1467"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01467-1","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Minsong Xue, QingLin Xu, Haoran Wu, Yao Tang, Zhiwei Luo, WenYu Gao, Yuexiang Deng, Lijun Hou, Xiaoning Li, and Zhikuan Yang have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol was approved by the Ethics Committee of Changsha Aier Eye Hospital (ID: KYPJ021) and adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}